Conference Coverage
Conference Coverage
VIDEO: AIs associated with endothelial dysfunction, a predictor of CVD
SAN ANTONIO – Aromatase inhibitors (AIs) appear to be associated with declines in vascular endothelial function, which in turn have been...
Conference Coverage
Narrow band imaging could expand endometriosis detection
ORLANDO
Conference Coverage
It’s elementary: Watson aids in breast cancer decisions
SAN ANTONIO – In this case, Watson is an artificial intelligence platform being developed in the United States and used in clinical practice in...
Conference Coverage
VIDEO: Watson for Oncology offers electronic curbside consults in breast cancer
Andrew Norden, MD, describes how Watson for Oncology works, and how different versions of the Watson platform are being used in medicine...
Conference Coverage
Aromatase inhibitor effect on endothelial function may lead to CVD
Aromatase inhibitors appear to have a decremental effect on vascular endothelial function, which could contribute to cardiovascular disease.
Conference Coverage
VIDEO: No effect of BRCA status on overall outcomes in early-onset breast cancer
SAN ANTONIO – No difference in outcomes was seen among young BRCA gene mutation carriers and noncarriers with early stage invasive breast cancer...
Conference Coverage
Increasing maternal vaccine uptake requires paradigm shift
Reimbursement-related issues topped the reasons that ob.gyns. found it burdensome to stock and administer vaccines. The most commonly reported...
Conference Coverage
VIDEO: No improvement in pCR with dual ER and HER2 inhibition
SAN ANTONIO
Conference Coverage
Optimal duration of extended AI therapy? Flip a coin
SAN ANTONIO – The optimal duration of aromatase inhibitor therapy following 5 years of endocrine therapy in postmenopausal women is still unknown...
Conference Coverage
VIDEO: Investigator discusses fulvestrant/everolimus combo
SAN ANTONIO – Most women with hormone receptor–positive breast cancer treated with an aromatase inhibitor will eventually develop resistance to...
Conference Coverage
New-onset pain rare after Essure placement
ORLANDO – While some women report new-onset pelvic pain after placement of an Essure sterilization device, results of a retrospective study...